Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • 3 Indian-origin...

    3 Indian-origin healthcare startup executives charged in USD 1 billion fraud in US

    Farhat NasimWritten by Farhat Nasim Published On 2019-11-27T11:59:50+05:30  |  Updated On 14 Aug 2021 11:34 AM IST

    The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of fraud "that targeted the company's clients, lenders and investors," the US Department of Justice said on Monday.


    New Delhi: Three Indian-origin ex-executives of a Chicago-based health tech start-up have been charged by the federal authorities for their alleged roles in a fraud scheme which involved falsifying the company's financial performance to raise nearly $1 billion in debt and private equity.


    The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of fraud "that targeted the company's clients, lenders and investors," the US Department of Justice said on Monday.




    "Outcome's former executives and employees allegedly deceived lenders, investors, and their own auditors by falsely representing revenue for additional profit," said Principal Deputy Assistant Attorney General John P Cronan of the Justice Department's Criminal Division.


    "The charges announced today demonstrate that lies and deception cannot serve as the basis for any company, including start-up companies, to falsely grow revenue for additional capital and private gain," Cronan said.


    Also Read: Diabetes Test Strips Fraud: Roche sues US executives for $84 million


    Shah and Agarwal co-founded the health care advertising company and owned it in 2015 and 2016 when the alleged fraud occurred.


    According to the Justice Department, from 2011 to 2017, the former executives and employees of Outcome sold tens of millions of dollars of an advertising inventory that did not exist.


    This allegedly resulted in inflated financial statements that the former executives used to raise nearly $ 1 billion in debt and equity financing in 2016 and 2017, it said in a statement.


    "The deception alleged to have been committed by the defendants tricked clients into paying for advertising it failed to deliver and served to falsely inflate the value of Outcome Health," said Assistant US Attorney Brian Hayes, Chief of the Criminal Division for the Northern District of Illinois.


    "These charges demonstrate that the FBI and its partners will hold businesses accountable for their misconduct," said Deputy Special Agent in Charge Larry L Lapp of the FBI's Chicago Field Office.


    The defendants were charged with allegedly over-inflating the company's revenue figures in order to fraudulently obtain loans from banks, said Inspector General Jay N Lerner of the Federal Deposit Insurance Corporation's Office of Inspector General (FDIC-OIG).


    Shah, Agarwal and Purdy are each charged with various counts of mail fraud, wire fraud and bank fraud. Purdy is also charged with one count of false statements to a financial institution, and Shah is also charged with two counts of transactions in criminal proceeds. Desai is charged with one count of wire fraud, the statement said.


    Also Read: Fortis Healthcare gets a notice from fraud investigation office seeking information

    Ashik DesaiFBIHealthcarehealthcare fraudhealthcare startupIndian startupInvestorsoutcomeOutcome HealthRishi ShahShradha AggarwalUSus justice dept
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok